• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镓-FAPI-04 与 F-FDG 在转移性乳腺癌的纵向临床前 PET 成像中的比较。

Ga-FAPI-04 vs. F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer.

机构信息

Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Rd., Shanghai , 200127, China.

College of Medical Imaging, Shanghai University of Medicine & Healthy Science, Shanghai, 201318, China.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):290-300. doi: 10.1007/s00259-021-05442-9. Epub 2021 Jun 28.

DOI:10.1007/s00259-021-05442-9
PMID:34181060
Abstract

PURPOSE

This longitudinal study aims to evaluate the performance of  Ga-FAPI-04 and F-FDG and to profile the dynamic process of tumor metastasis in a preclinical 4T1 breast cancer model. Although both of these two radioligands are wildly used in clinic, no study was reported on their performance in the longitudinal monitoring of tumor metastasis. Also, no correlation between the expression level of fibroblast activation protein (FAP) and the development of tumor metastasis has been elucidated previously. In this study, we evaluated the performance of  Ga-FAPI-04 and F-FDG PET during the entire process of tumor metastasis, and their potential for the early diagnosis of tumor metastasis. We also clarified the correlation of uptakes as well as the signal-to-background (S/B) ratios between these two probes at different stages of tumor metastasis.

METHODS

Forty 4T1 metastatic breast cancer murine models were established using female BALB/c mice, followed by the longitudinal imaging with  Ga-FAPI-04 and F-FDG once a week for up to 6 weeks. In vitro hematoxylin and eosin (H&E) and immunochemistry (IHE) staining were performed to evaluate FAP expression on the metastatic lesions. Further statistical analysis was performed to evaluate the correlation of  Ga-FAPI-04 and F-FDG uptake (%ID/cc) at different stages of the metastasis.

RESULTS

Ga-FPAI-04 holds an advantage over F-FDG with higher sensitivity at the early stage of tumor metastasis. However, with the progress of tumor metastasis, uptake of  Ga-FAPI-04 decreases and becomes less sensitive than F-FDG. There is also no direct correlation between uptake or S/B ratios of  Ga-FAPI-04 and F-FDG during this dynamic process.

CONCLUSION

Ga-FAPI-04 is more sensitive than F-FDG in detecting the early stage of tumor metastasis, but becomes less sensitive than F-FDG at the late stage of tumor metastasis. We envision this result would be meaningful for the explanation of the  Ga-FAPI-04 and F-FDG imaging both in the future clinic and preclinic studies.

摘要

目的

本纵向研究旨在评估 Ga-FAPI-04 和 F-FDG 的性能,并在临床前 4T1 乳腺癌模型中描绘肿瘤转移的动态过程。尽管这两种放射性配体在临床上都被广泛应用,但目前尚无研究报道它们在肿瘤转移的纵向监测中的性能。此外,之前也没有阐明成纤维细胞激活蛋白(FAP)的表达水平与肿瘤转移发展之间的相关性。在本研究中,我们评估了 Ga-FAPI-04 和 F-FDG PET 在肿瘤转移整个过程中的性能及其对肿瘤转移早期诊断的潜力。我们还阐明了在肿瘤转移的不同阶段,这两种探针摄取之间以及信号与背景(S/B)比值之间的相关性。

方法

使用雌性 BALB/c 小鼠建立了 40 例转移性 4T1 乳腺癌小鼠模型,随后每周进行一次 Ga-FAPI-04 和 F-FDG 的纵向成像,最长可达 6 周。进行体外苏木精和伊红(H&E)和免疫组织化学(IHE)染色,以评估转移病灶上的 FAP 表达。进一步进行统计分析,以评估不同转移阶段的 Ga-FAPI-04 和 F-FDG 摄取(%ID/cc)之间的相关性。

结果

Ga-FPAI-04 在肿瘤转移的早期阶段比 F-FDG 具有更高的灵敏度。然而,随着肿瘤转移的进展,Ga-FAPI-04 的摄取减少,其灵敏度低于 F-FDG。在这个动态过程中,Ga-FAPI-04 和 F-FDG 的摄取或 S/B 比值之间也没有直接的相关性。

结论

Ga-FAPI-04 在检测肿瘤转移的早期阶段比 F-FDG 更敏感,但在肿瘤转移的晚期阶段,其灵敏度低于 F-FDG。我们设想,这一结果对于未来临床和临床前研究中 Ga-FAPI-04 和 F-FDG 成像的解释具有重要意义。

相似文献

1
Ga-FAPI-04 vs. F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer.镓-FAPI-04 与 F-FDG 在转移性乳腺癌的纵向临床前 PET 成像中的比较。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):290-300. doi: 10.1007/s00259-021-05442-9. Epub 2021 Jun 28.
2
Head-to-Head Comparison of [ Ga]Ga-FAPI-46-PET/CT and [F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer.头对头比较[Ga]Ga-FAPI-46-PET/CT 和 [F]F-FDG-PET/CT 对头颈部癌症放疗计划的作用。
Mol Imaging Biol. 2022 Dec;24(6):986-994. doi: 10.1007/s11307-022-01749-7. Epub 2022 Jun 30.
3
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using Ga-FAP-2286: Comparison with F-FDG and Ga-FAPI-46 in a Single-Center, Prospective Study.使用 Ga-FAP-2286 对多种癌症中的成纤维细胞激活蛋白进行 PET 成像:在单中心前瞻性研究中与 F-FDG 和 Ga-FAPI-46 的比较。
J Nucl Med. 2023 Mar;64(3):386-394. doi: 10.2967/jnumed.122.264544. Epub 2022 Sep 2.
4
Ga-FAPI PET/CT as an Alternative to F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma.镓-FAPI PET/CT 可作为侵袭性小叶乳腺癌成像的 F-FDG PET/CT 替代方法。
J Nucl Med. 2024 Apr 1;65(4):512-519. doi: 10.2967/jnumed.123.266798.
5
Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of Ga-FAPI PET/CT and F-FDG PET/CT.成纤维细胞激活蛋白与淋巴瘤诊断中的糖酵解:Ga-FAPI PET/CT 与 F-FDG PET/CT 的比较。
J Nucl Med. 2023 Sep;64(9):1399-1405. doi: 10.2967/jnumed.123.265530. Epub 2023 Jun 29.
6
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.头颈部肿瘤 Ga-FAPI-46 PET/CT 与 18F-FDG PET/CT 对比用于淋巴结分期的初步临床经验
Clin Nucl Med. 2023 Feb 1;48(2):150-155. doi: 10.1097/RLU.0000000000004505.
7
The potential utility of [ Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [F]FDG.[68Ga]Ga-DOTA-FAPI-04 作为一种新型广谱肿瘤和非肿瘤成像剂的潜在应用——与[18F]FDG 比较。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):963-979. doi: 10.1007/s00259-021-05522-w. Epub 2021 Aug 19.
8
Diagnostic Potential of Supplemental Static and Dynamic Ga-FAPI-46 PET for Primary F-FDG-Negative Pulmonary Lesions.静态和动态 Ga-FAPI-46 PET 对原发性 F-FDG 阴性肺部病变的诊断潜力。
J Nucl Med. 2024 Jun 3;65(6):872-879. doi: 10.2967/jnumed.123.267103.
9
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.在一个包含324例患者和21种肿瘤实体的单中心数据库中进行的成纤维细胞激活蛋白PET与组织病理学研究
J Nucl Med. 2023 May;64(5):711-716. doi: 10.2967/jnumed.122.264689. Epub 2022 Dec 29.
10
Ga-FAPI-04 Positron Emission Tomography Distinguishes Malignancy From F-FDG-Avid Colorectal Lesions.镓-FAPI-04 正电子发射断层扫描可区分恶性与 F-FDG 摄取的结直肠病变。
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):285-294. doi: 10.1016/j.ijrobp.2023.08.019. Epub 2023 Aug 25.

引用本文的文献

1
Preclinical evaluation of [Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP).[镓]Ga-AAZTA-FAPI-46的临床前评估:一种用于靶向成纤维细胞活化蛋白(FAP)的新型正电子发射断层显像(PET)示踪剂
EJNMMI Radiopharm Chem. 2025 Aug 5;10(1):51. doi: 10.1186/s41181-025-00375-2.
2
Performance of [Ga]Ga-FAPI-04 PET/CT imaging in hepatic vascular-associated mesenchymal tumor: comparison with [F]FDG PET/CT.[镓]Ga-FAPI-04 PET/CT成像在肝血管相关间充质瘤中的表现:与[氟]FDG PET/CT的比较
Eur J Nucl Med Mol Imaging. 2025 Jul 24. doi: 10.1007/s00259-025-07446-1.
3
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways.
探索肾上腺皮质癌中目前可用的成纤维细胞活化蛋白靶向分子:探寻诊疗途径。
Eur J Nucl Med Mol Imaging. 2025 Mar 22. doi: 10.1007/s00259-025-07203-4.
4
Preclinical evaluation of Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor-positive breast cancer.铜标记西妥昔单抗在免疫正电子发射断层显像中用于检测表皮生长因子受体阳性乳腺癌前哨淋巴结转移的临床前评估
Breast Cancer Res. 2025 Mar 7;27(1):33. doi: 10.1186/s13058-025-01972-4.
5
Assessment of viable tumours by [Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.肝细胞癌患者局部区域治疗后用[镓]镓-FAPI-04 PET/CT评估存活肿瘤
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2132-2144. doi: 10.1007/s00259-024-07062-5. Epub 2025 Jan 20.
6
[Ga]Ga-FAPI PET/CT in brain tumors: comparison with [F]F-FDG PET/CT.[镓]镓-FAPI PET/CT在脑肿瘤中的应用:与[氟]氟-FDG PET/CT的比较。
Front Oncol. 2024 Sep 6;14:1436009. doi: 10.3389/fonc.2024.1436009. eCollection 2024.
7
Applications of FAPI PET/CT in the diagnosis and treatment of breast and the most common gynecologic malignancies: a literature review.FAPI PET/CT在乳腺癌及最常见妇科恶性肿瘤诊断与治疗中的应用:一项文献综述
Front Oncol. 2024 Mar 5;14:1358070. doi: 10.3389/fonc.2024.1358070. eCollection 2024.
8
Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.乳腺癌中分子靶标和代谢途径的影像学研究:改善临床管理的现状和未来展望。
Int J Mol Sci. 2024 Jan 26;25(3):1575. doi: 10.3390/ijms25031575.
9
Physiological Uptake Characteristics of Breast on Ga-FAPI-04 PET/CT.乳腺 Ga-FAPI-04 PET/CT 的生理学摄取特征。
Mol Imaging Biol. 2023 Dec;25(6):1045-1053. doi: 10.1007/s11307-023-01872-z. Epub 2023 Nov 9.
10
Advances in PET/CT Imaging for Breast Cancer Patients and Beyond.乳腺癌及其他疾病患者的PET/CT成像进展
J Clin Med. 2023 Jan 13;12(2):651. doi: 10.3390/jcm12020651.